Decreased enrollment in breast cancer trials by histologic subtype: does invasive lobular carcinoma resist RECIST?

Abstract Enrollment in metastatic breast cancer trials usually requires measurable lesions, but patients with invasive lobular carcinoma (ILC) tend to form diffuse disease. We found that the proportion of patients with metastatic ILC enrolled in clinical trials at our institution was significantly l...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Mary Kathryn Abel, Michelle E. Melisko, Hope S. Rugo, A. Jo Chien, Italia Diaz, Julia K. Levine, Ann Griffin, Joseph McGuire, Laura J. Esserman, Hala T. Borno, Rita A. Mukhtar
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Nature Portfolio 2021-10-01
coleção:	npj Breast Cancer
Acesso em linha:	https://doi.org/10.1038/s41523-021-00348-z
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!